Research Library › Articles · View in catalog →
Gepon
Also indexed as Geponum
1 Identity
Linear synthetic tetradecapeptide, all-L. A Russian-developed immunomodulator. and listed by one seller as "Gepon peptide 10MG vial" and "Gepon peptide 200MG liquid spray".
- Sequence
- Thr-Glu-Lys-Lys-Arg-Arg-Glu-Thr-Val-Glu-Arg-Glu-Lys-Glu (TEKKRRETVEREKE), 14 residues, free termini.
- Molecular formula
- C74H132N26O27, as stated on one seller's product specification and by one institutional catalog.
- Average mass
- 1818.025 Da for C74H132N26O27.
- Monoisotopic mass
- 1816.97552 Da monoisotopic neutral; [M+H]+ 1817.98280. Both figures are calculated from a formula stated by suppliers and not from an independent structural determination; a formula from a seller and a formula from a structure determination are not the same evidence, so the masses stand as derived rather than measured values.
- Salt / variant note
- No close mass collision has been identified in the catalog. The peptide is unusually charge-dense — six basic residues against five acidic — which gives it distinctive chromatographic behavior but also makes it prone to co-eluting with nothing at all on conventional C18, a practical characterization problem rather than an identity one.
2 Class & testing panel
- Form
- Single article
- Testing panel
- P1 — panel definition
3 Primary sources & evidence
Identity evidence is moderate: a formula stated by one seller and corroborated by one institutional catalog, with masses derived from that formula rather than measured. Regulatory evidence is clear — Russian registration is documented and US approval is absent.
4 Storage & specification
- Storage
- Not assigned; the article is not offered.
- Shelf life
- Not assigned; the article is not offered.
This record reports identity, specification and study design. It does not state what the article does in a human body. Supplied under the caution: “CAUTION: Contains a new drug for investigational use only in laboratory research animals or for tests in vitro. Not for use in humans.”
